Osteonecrosis News and Research

RSS
FDA approves Prolia for postmenopausal women with osteoporosis

FDA approves Prolia for postmenopausal women with osteoporosis

Use of bisphosphonates associated with risk of developing BON after dental surgery: Study

Use of bisphosphonates associated with risk of developing BON after dental surgery: Study

ACOEM publishes new medical treatment guidelines for hip and groin disorders

ACOEM publishes new medical treatment guidelines for hip and groin disorders

Research reveals therapeutic benefit of ACTH in treatment of osteonecrosis

Research reveals therapeutic benefit of ACTH in treatment of osteonecrosis

Potential new treatment for osteonecrosis

Potential new treatment for osteonecrosis

Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases

Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Amgen to present its four Phase 3 clinical trial results

Amgen to present its four Phase 3 clinical trial results

Denosumab reduces fracture risk in men receiving androgen-deprivation therapy for prostate cancer

Denosumab reduces fracture risk in men receiving androgen-deprivation therapy for prostate cancer

X-rays help predict permanent bone damage from bisphosphonates

X-rays help predict permanent bone damage from bisphosphonates

Childhood Varicella zoster could affect oral health years later

Childhood Varicella zoster could affect oral health years later

Oral bisphosphonates linked to increased jaw necrosis

Oral bisphosphonates linked to increased jaw necrosis

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

FDA approves Actonel (risedronate sodium) for postmenopausal osteoporosis

FDA approves Actonel (risedronate sodium) for postmenopausal osteoporosis